WESTON HOUSE PRACTICE — All Prescriptions & Medications — Page 13
Practice Code: L84033 | CHELTENHAM, GL50 4DP
Showing results 601-650 of 720
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Dicycloverine hydrochloride | 20 | 9,220 | £13.4K | +68.9% ▲ |
| Formoterol fumarate | 20 | 20 | £463 | +39.5% ▲ |
| Aspirin | 20 | 776 | £50 | +103.5% ▲ |
| Pimecrolimus | 20 | 600 | £374 | +18.1% ▲ |
| Phenazone/lidocaine | 19 | 285 | £161 | +85.8% ▲ |
| Crotamiton | 19 | 1,890 | £110 | +14.3% ▲ |
| Fluocinolone acetonide | 19 | 720 | £119 | +74.5% ▲ |
| 19 | 795 | £1.7K | +7.8% ▲ | |
| Glycopyrronium bromide | 18 | 4,420 | £3.3K | -12.3% ▼ |
| Fluvastatin sodium | 18 | 672 | £87 | -22.2% ▼ |
| Guaifenesin | 18 | 7,200 | £228 | +525.0% ▲ |
| Potassium chloride | 18 | 2,360 | £237 | -3.7% ▼ |
| Mupirocin | 18 | 57 | £77 | +53.3% ▲ |
| 18 | 104 | £291 | +115.6% ▲ | |
| 18 | 870 | £4.2K | +187.8% ▲ | |
| Salmeterol | 17 | 27 | £751 | -29.3% ▼ |
| Naratriptan hydrochloride | 17 | 108 | £21 | -35.0% ▼ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 17 | 53.9K | £1.6K | -36.0% ▼ |
| Other individually formulated bought in preparations | 17 | 1,310 | £136 | -48.0% ▼ |
| 17 | 206 | £306 | +55.3% ▲ | |
| 17 | 5,760 | £220 | +89.1% ▲ | |
| Inclisiran | 16 | 16 | £756 | +27.0% ▲ |
| Frovatriptan | 16 | 212 | £497 | +13.2% ▲ |
| Drospirenone | 16 | 1,456 | £242 | +148.6% ▲ |
| Powder 3.7 kcal/g energy and protein fortifier (0913081) | 16 | 1,470 | £3.4K | +156.5% ▲ |
| 16 | 600 | £3.0K | -28.3% ▼ | |
| Zinc oxide | 15 | 312 | £41 | -27.5% ▼ |
| Telmisartan | 15 | 840 | £225 | -74.1% ▼ |
| Amantadine hydrochloride | 15 | 1,036 | £234 | -46.1% ▼ |
| Tablets/capsules micronutrient supplement (0913282) | 15 | 732 | £495 | +43.2% ▲ |
| Leflunomide | 15 | 600 | £35 | -60.4% ▼ |
| Imiquimod | 15 | 190 | £711 | +111.1% ▲ |
| Malathion | 15 | 3,150 | £286 | +134.9% ▲ |
| 15 | 183 | £165 | +70.6% ▲ | |
| 15 | 160 | £323 | +211.5% ▲ | |
| 15 | 945 | £46 | -11.2% ▼ | |
| 15 | 35 | £1.2K | +192.3% ▲ | |
| 15 | 690 | £474 | +105.3% ▲ | |
| 15 | 140 | £464 | -7.4% ▼ | |
| Nadolol | 14 | 448 | £296 | +38.4% ▲ |
| Trifluoperazine | 14 | 4,012 | £2.1K | -7.2% ▼ |
| Aripiprazole | 14 | 14 | £3.1K | -8.1% ▼ |
| Hydromorphone hydrochloride | 14 | 784 | £124 | -5.9% ▼ |
| Rotigotine | 14 | 392 | £1.5K | -48.1% ▼ |
| Vildagliptin | 14 | 784 | £234 | -3.5% ▼ |
| Cabergoline | 14 | 160 | £280 | -9.7% ▼ |
| Magnesium citrate | 14 | 796 | £304 | +93.6% ▲ |
| Powder preterm infant formula (0913111) | 14 | 22.4K | £362 | -12.1% ▼ |
| Febuxostat | 14 | 728 | £77 | -62.5% ▼ |
| Loteprednol etabonate | 14 | 105 | £110 | +51.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.